Safety and Efficacy of a Non-replicating ChAdOx1 Vector Vaccine AZD1222 (COVISHIELD), for Prevention of COVID-19 in Patients With Liver Cirrhosis

NCT04794946 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

2200

Enrollment

OTHER

Sponsor class

Conditions

Liver Cirrhosis

Interventions

BIOLOGICAL: Covishield

Sponsor

Institute of Liver and Biliary Sciences, India